Cargando…
Fluorescent labelling of the actin cytoskeleton in plants using a cameloid antibody
BACKGROUND: Certain members of the Camelidae family produce a special type of antibody with only one heavy chain. The antigen binding domains are the smallest functional fragments of these heavy-chain only antibodies and as a consequence have been termed nanobodies. Discovery of these nanobodies has...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4036722/ https://www.ncbi.nlm.nih.gov/pubmed/24872838 http://dx.doi.org/10.1186/1746-4811-10-12 |
_version_ | 1782318191965372416 |
---|---|
author | Rocchetti, Alessandra Hawes, Chris Kriechbaumer, Verena |
author_facet | Rocchetti, Alessandra Hawes, Chris Kriechbaumer, Verena |
author_sort | Rocchetti, Alessandra |
collection | PubMed |
description | BACKGROUND: Certain members of the Camelidae family produce a special type of antibody with only one heavy chain. The antigen binding domains are the smallest functional fragments of these heavy-chain only antibodies and as a consequence have been termed nanobodies. Discovery of these nanobodies has allowed the development of a number of therapeutic proteins and tools. In this study a class of nanobodies fused to fluorescent proteins (chromobodies), and therefore allowing antigen-binding and visualisation by fluorescence, have been used. Such chromobodies can be expressed in living cells and used as genetically encoded immunocytochemical markers. RESULTS: Here a modified version of the commercially available Actin-Chromobody® as a novel tool for visualising actin dynamics in tobacco leaf cells was tested. The actin-chromobody binds to actin in a specific manner. Treatment with latrunculin B, a drug which disrupts the actin cytoskeleton through inhibition of polymerisation results in loss of fluorescence after less than 30 min but this can be rapidly restored by washing out latrunculin B and thereby allowing the actin filaments to repolymerise. To test the effect of the actin-chromobody on actin dynamics and compare it to one of the conventional labelling probes, Lifeact, the effect of both probes on Golgi movement was studied as the motility of Golgi bodies is largely dependent on the actin cytoskeleton. With the actin-chromobody expressed in cells, Golgi body movement was slowed down but the manner of movement rather than speed was affected less than with Lifeact. CONCLUSIONS: The actin-chromobody technique presented in this study provides a novel option for in vivo labelling of the actin cytoskeleton in comparison to conventionally used probes that are based on actin binding proteins. The actin-chromobody is particularly beneficial to study actin dynamics in plant cells as it does label actin without impairing dynamic movement and polymerisation of the actin filaments. |
format | Online Article Text |
id | pubmed-4036722 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-40367222014-05-29 Fluorescent labelling of the actin cytoskeleton in plants using a cameloid antibody Rocchetti, Alessandra Hawes, Chris Kriechbaumer, Verena Plant Methods Methodology BACKGROUND: Certain members of the Camelidae family produce a special type of antibody with only one heavy chain. The antigen binding domains are the smallest functional fragments of these heavy-chain only antibodies and as a consequence have been termed nanobodies. Discovery of these nanobodies has allowed the development of a number of therapeutic proteins and tools. In this study a class of nanobodies fused to fluorescent proteins (chromobodies), and therefore allowing antigen-binding and visualisation by fluorescence, have been used. Such chromobodies can be expressed in living cells and used as genetically encoded immunocytochemical markers. RESULTS: Here a modified version of the commercially available Actin-Chromobody® as a novel tool for visualising actin dynamics in tobacco leaf cells was tested. The actin-chromobody binds to actin in a specific manner. Treatment with latrunculin B, a drug which disrupts the actin cytoskeleton through inhibition of polymerisation results in loss of fluorescence after less than 30 min but this can be rapidly restored by washing out latrunculin B and thereby allowing the actin filaments to repolymerise. To test the effect of the actin-chromobody on actin dynamics and compare it to one of the conventional labelling probes, Lifeact, the effect of both probes on Golgi movement was studied as the motility of Golgi bodies is largely dependent on the actin cytoskeleton. With the actin-chromobody expressed in cells, Golgi body movement was slowed down but the manner of movement rather than speed was affected less than with Lifeact. CONCLUSIONS: The actin-chromobody technique presented in this study provides a novel option for in vivo labelling of the actin cytoskeleton in comparison to conventionally used probes that are based on actin binding proteins. The actin-chromobody is particularly beneficial to study actin dynamics in plant cells as it does label actin without impairing dynamic movement and polymerisation of the actin filaments. BioMed Central 2014-05-19 /pmc/articles/PMC4036722/ /pubmed/24872838 http://dx.doi.org/10.1186/1746-4811-10-12 Text en Copyright © 2014 Rocchetti et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Methodology Rocchetti, Alessandra Hawes, Chris Kriechbaumer, Verena Fluorescent labelling of the actin cytoskeleton in plants using a cameloid antibody |
title | Fluorescent labelling of the actin cytoskeleton in plants using a cameloid antibody |
title_full | Fluorescent labelling of the actin cytoskeleton in plants using a cameloid antibody |
title_fullStr | Fluorescent labelling of the actin cytoskeleton in plants using a cameloid antibody |
title_full_unstemmed | Fluorescent labelling of the actin cytoskeleton in plants using a cameloid antibody |
title_short | Fluorescent labelling of the actin cytoskeleton in plants using a cameloid antibody |
title_sort | fluorescent labelling of the actin cytoskeleton in plants using a cameloid antibody |
topic | Methodology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4036722/ https://www.ncbi.nlm.nih.gov/pubmed/24872838 http://dx.doi.org/10.1186/1746-4811-10-12 |
work_keys_str_mv | AT rocchettialessandra fluorescentlabellingoftheactincytoskeletoninplantsusingacameloidantibody AT haweschris fluorescentlabellingoftheactincytoskeletoninplantsusingacameloidantibody AT kriechbaumerverena fluorescentlabellingoftheactincytoskeletoninplantsusingacameloidantibody |